לקריאת מידע כללי לפי נושאים:


 
תה פרשונית

 
 

 

Pressure tea contains: – Tilia, Salvia Officinalis, Passiflora, Olive Leaves, Hibiscus, Inula Helenium, Silybum Marianum (Gadilan), Taraxacum (Dandelion), Citrus, Lemon Verbena, Pomegranate.

 

Seientific publications and more material about healing herbs

 

 

 

Tilia

 

 

Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin: American Botanical Council and Boston: Integrative Medicine Communications, 1998, 163.

 

Viola H, Wolfman C, Levi de Stein M, et al. Isolation of pharmacologically active benzodiazepine receptor ligands from Tilia tomentosa (Tiliaceae). J Ethnopharmacol 1994;44:47–53.

 

Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin: American Botanical Council and Boston: Integrative Medicine Communications, 1998, 163.

 

McGuffin M, Hobbs C, Upton R, Goldberg A (eds). American Herbal Product Association’s Botanical Safety Handbook. Boca Raton, FL: CRC Press, 1997, 116.

 

Bove M. An Encyclopedia of Natural Healing for Children and Infants. New Canaan, CT: Keats Publishing, 1996, 234–5.

 

Wren RC, Williamson EM, Evans FJ. Potter’s New Cyclopaedia of Botanical Drugs and Preparations. Essex, UK: Saffron Walden, CW Daniel Co, 1988, 171.

 

Duke JA. CRC Handbook of Medicinal Herbs. Boca Raton, FL: CRC Press, 1985, 485–6.

 

Fiegel VG, Hohensee F. Experimental and clinical screening of a dry, water extract of tiliae libri. Arzneim Forsch 1963;13:222–5 [in German].

 

Sadek HM. Treatment of hypertonic dyskinesias of Oddi’s sphincter using a wild Tilia suspension. Hospital (Rio J) 1970;77:141–7 [in Portuguese].

 

Langer M. Clinical observations on an antispastic factor extracted from Tiliae silvestris alburnum. Clin Ter 1963;25:438–44 [in Italian].

 

Weiss RF. Herbal Medicine. Gothenburg, Sweden: Ab Arcanum and Beaconsfield, UK: Beaconsfield Publishers, 1985, 227–8.

 

Tyler VE. The Honest Herbal--A Sensible Guide to the Use of Herbs and Related Remedies. Philadelphia: George F. Stickley, 1982, 263.

 

 

Salvia Officinalis

 
Kennedy D, Pace S, Haskell C, Okello E, Milne A, Scholey A. Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery. Neuropsychopharmacol. 2006;31:845-852.
 
1Kennedy DO, Scholey AB, Tildesley N, et al. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacol Biochem Behav. 2002;72(4):953-64.
2Kennedy DO, Wake G, Savelev S, et al. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology. 2003;28(10):1871-1881.

 

British Herbal Pharmacopoeia (1983). British Herbal Medicine Association U.K.

 

Keller, m.s.(1978). Mysterious Herbs and roots. Culver City Calif: peace Press. Pp. 300 – 314.

 

Tyler, V.E. (1994). Herbs of Choice. New York: Pharmaceutical Products Press. P. 164.

 

 

PASSIFLORA

 

Passiflorae herba, Passiflora, ESCOP Monograph, Published by the European Scientific Cooperative on Phytotherapy, 1997.

 

 Capasso A. Pinto A. Experimental investigations of the synergistic sedative effect of Passiflora and Kava. Acta Ther. 21: 127-140, 1995.

 

 

Galliano G. Foussard-Blanpin O. Bretaudeau J. Etude experimental du role dumaltol dans les proprietes psycho-pharmacologiques de Passiflora incarnata L. (Passifloraceae) Phytotherapy 40-41: 18-22, 1994.

 

Speeroni EE. Minghetti A. Neuropharmacological activity of extract from Passiflora incarnate. Planta Med. 54:488-491,1988.

 

 

Buchbauer G. Jirovatzz I. Volatile constituents of the essential oil of Passiflora incarnate. J. Essent Oil Res. 4: 329-994, 1992.

 

Spencer KC. Seigler DS. Gynocardin from Passiflora. Planta Med 50:334-356, 1992.

 

Foster S. Herbs for Your Health. Loveland, CO: Interweave Press, 1996, 68–9.

 

 

Akhondzadeh S, Naghavi HR, Vazirian M, et al. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther 2001;26:363–7.

 

 

Meier B. Passiflora incarnata L.—Passion flower: Portrait of a medicinal plant. Zeitschrift Phytother 1995;16:115–26.

 

 

Wichtl M. Herbal Drugs and Phytopharmaceuticals. Boca Raton, FL: CRC Press, 1994, 363–5.

 

 

Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-Care Professionals. London: Pharmaceutical Press, 1996, 206–7.

 

 

Fisher AA, Purcell P, Le Couteur DG. Toxicity of Passiflora incarnata L. J Toxicol Clin Toxicol 2000;38:63–6.

 
 
 

Olive Leaves

 

Phytomedicine, 2004 Feb.; 11 (2-3): 121-129.

 

Planta Medica, 1992 Dec.; 58 (6): 513-515.

 

Visioli F. and Gali C. Oleuropein protects low density lipoprotein from oxidation. Life Science 55: 1965-1971, 1994.

 

Tassou CC. Nychas GJE. Board RG. Effect of phenolic  compounds and oleuropein on the germination of Bacillus cereus T. spores Biotechnology Applied Biochemistry 13: 231-237, 1991.

 

Pasquale AD. Monforte MT. Calaro ML. HPLC analysis of oleuropein and some Flavonoids in leaf and bud of Olea europea L. II Farmaco, 46 :803-815,1991.

 

Keville K. OLIVE, Olea europaea, The American Herb Association, 13: 3-4, 1997.

 

Wren RC. Potter’s New Cyclopedia of Botanical Drugs and Preparations. Essex, England: CW Daniel Co., 1985, 204.

 

Bruneton J. Pharmacognosy, Phytochemistry, Medicinal Plants. Paris, France: Technique & Documentation-Lavoisier, 1995, 487–9.

 

Peirce A. Practical Guide to Natural Medicines. New York: William Morrow and Co., 1999, 469–71.

 

Grieve M. A Modern Herbal, vol II. New York: Dover Publications, 1982, 598.

 

Foster S. 101 Medicinal Herbs. Loveland, CO: Interweave Press, 1998, 148–9.

 

Bruneton J. Pharmacognosy, Phytochemistry, Medicinal Plants. Paris, France: Technique & Documentation-Lavoisier, 1995, 487–9.

 

Petkov V, Manolov P. Pharmacological analysis of the iridoid oleuropein. Arzneim Forsch/Drug Research 1972;22:1476–86.

 

 Weiss RF. Herbal Medicine. Gothenburg, Sweden: AB Arcancum, 1988, 160–1.

 

Visioli F, Galli C. Oleuropein protects low density lipoprotein from oxidation. Life Sciences 1994;55:1965–71.

 

Fleming HP, Walter WM, Etchells JL. Antimicrobial properties of oleuropein and products of its hydrolysis from green olives. Applied Microbiol 1973;26:777–82.

 

Foster S. 101 Medicinal Herbs. Loveland, CO: Interweave Press, 1998, 148–9.

 

Petkov V, Manolov P. Pharmacological analysis of the iridoid oleuropein. Arzneim Forsch/Drug Research 1972; 22:1476–86.

 

Eliot GA. Buthala DA. DeYong EN. Preliminary safety studies with calcium elenolate, an antiviral agent. Antimicrobial Agents and Chemotherapy, 173-176, 1969.

 

Renis HE. In vitro antiviral activity of calcium elenolate . Antimicrobial Agents and Chemotherapy, 167-168, 1970.

 

 

 

Hibiscus

 

Haji Faraji M, Haji Tarkhani A. The effect of sour tea (Hibiscus sabdariffa) on essential hypertension. J Ethnopharmacol 1999;65:231–6.

 
 

 

Inula Helenium

 

Gay-Crosier F, Schreiber G, Hauser C. Anaphylaxis from inulin in vegetables and processed food. N Engl J Med 2000;342:1372.

 

Gruenwald J, Brendler T, Jaenicke C, et al. (eds). PDR for Herbal Medicines. Montvale, NJ: Medical Economics, 1998, 912–3.

 

Newall CA. et al. Herbal Medicines, A Guide for Health care Professionals, Pharmaceutical Press, 1996.

 

Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics. New York: John Wiley & Sons, 1996, 222–4.

 

Wichtl M. Herbal Drugs and Phytopharmaceuticals. Boca Raton, FL: CRC Press, 1994, 254–6.

 

Duke, JA. Handbook of Phytochemical Constituents of GRAS Herbs and Other Economic Plants. Boca Raton, FL; CRC Press, 1992.

 

Wichtl M. Herbal Drugs and Phytopharmaceuticals. Boca Raton, FL: CRC Press, 1994, 254–6.

 

Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-Care Professionals. London: The Pharmaceutical Press, 1996, 106–7.

 

Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin: American Botanical Council and Boston: Integrative Medicine Communications, 1998, 328–9.

 

Bradley PR (ed). British Herbal Compendium, vol. 1. Bournemouth, England: British Herbal Medicine Association, 1992, 87–8.

 

Carabin IG, Flamm WG. Evaluation of safety of inulin and oligofructose as dietary fiber. Regul Toxicol Pharmacol 1999;30:268–82.

 

Coussement PA. Inulin and oligofructose: safe intakes and legal status. J Nutr 1999;129:1412S–7S.

 

Tripathi YB. Et al. Assessment of the adrenergic beta blocking activity of Inula racemosa. J Ethnopharmacology, 23: 3-9, 1988.

 
 
 
(Silybum Marianum (Gdilan

 

Journal of Alternative and Complementary Medicine, 2003 Jun; 9 (3):411-466.

 

Gastroenterology Nursing, 2001 Mar.-Apr. 24 (2): 95-97.

 

Human and Experimental Toxicology, 1990 Jul.; 9 (4):235-244.

 

Wichtl, M.(1994), Herbal Drugs and Phytopharmaceuticals, Stuttgart: CRC Press Medpharm Scientific Publishers. 121 - 123.

 

Fiebig, M,. Wagner, H,.(1984), New antihepatotoxic effects of flavonolingnans of white flowering variety of Silybum. Planta Med. 50, 310 – 313.

 

 Hikino H, Kiso Y, Wagner H, Fiebig M. Antihepatotoxic actions of flavonolignans from Silybum marianum fruits. Planta Medica 1984;50:248–50.

 

Faulstich H, Jahn W, Wieland T. Silibinin inhibition of amatoxin uptake in the perfused rat liver. Arzneim-Forsch Drug Res 1980;30:452–4.

 

Tuchweber B, Sieck R, Trost W. Prevention by silibinin of phalloidin induced hepatotoxicity. Toxicol Appl Pharmacol 1979;51:265–75.

 

Feher J, Lang I, Deak G, et al. Free radicals in tissue damage in liver diseases and therapeutic approach. Tokai J Exp Clin Med 1986;11:121–34.

 

Gastroenterology, 1982; 17:417-421

 

Sonnenbichler J, Zetl I. Stimulating influence of a flavonolignan derivative on proliferation, RNA synthesis and protein synthesis in liver cells. In Assessment and Management of Hepatobiliary Disease, ed. L Okolicsanyi, G Csomos, G Crepaldi. Berlin: Springer-Verlag, 1987, 265–72.

 

Schuppan D, Strösser W, Burkard G, Walosek G. Legalon® lessens fibrosing activity in patients with chronic liver diseases. Zeits Allgemeinmed 1998;74:577–84.

 

Salmi HA, Sama S. Effect of silymarin on chemical, functional and morphological alterations of the liver. Scand J Gastroenterol 1982;17:517–21.

 

Leng-Peschlow E. Alcohol-related liver diseases-use of Legalon®. Z Klin Med 1994;2:22–7.

 

Ferenci P, Dragosics B, Dittrich H, et al. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol 1989;9:105–13.

 

Velussi M, Cernogoi AM, De Monte A, et al. Long-term (12 months) treatment with an antioxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. J Hepatology 1997;26:871–9.

 

Pares A, Plancs R, Torres M, et al. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J Hepatol 1998;28:615–21.

 

Nassuato G, Iemmolo RM, Strazzabosco M, et al. Effect of silibinin on biliary lipid composition. Experimental and clinical study. J Hepatol 1991;12:290–5.

 

Palasciano G, Portinascasa P, Palmieri V, et al. The effect of silymarin on plasma levels of malondialdehyde in patients receiving long-term treatment with psychotropic drugs. Curr Ther Res 1994;S5:S37–45.

 

Allain H, Schück S, Lebreton S, et al. Aminotransferase levels and silymarin in de novo tacrine-treated patients with Alzheimer’s disease. Dementia Geriatr Cogn Disorders 1999;10:181–5.

 

Brown DJ. Herbal Prescriptions for Better Health. Rocklin, CA: Prima Publishing, 1996, 151–8.

 

Reyes H. The spectrum of liver and gastrointestinal disease seen in cholestasis of pregnancy. Gastroert Clin N Am 1992;21:905–21.

 

Adverse Drug Reactions Advisory Committee. An adverse reaction to the herbal medication milk thistle (Silybum marianum). MJA 1999;170:218–9.

 
 

TARAXACUM (Dandelion)

 

Life Sciences, 2004 Jan. 16; 74(9): 1149-1157

 

Alternative Medicine Review, 1999 Apr.; 4(2): 112-114

 

Human and Experimental Toxicology, 1990 Jul.; 9(4): 235-244

 

ESCOP Taraxaci herba and Taraxaci radix. Monograph on the Medicinal Uses of Plant Drugs. Exeter, U.K. European Scientific Cooperative on Phytotherapy, 1997.

 

Hobbs C. Dandelion: A Monograph, Portland, OR, Eclectic Medicinal Publication, 1985.

 

Kuusi T. Pysalo H. Autio K. The bitterness of dandelion ll. Chemical investigations. Lebensum Wiss Technol. 18:347-349, 1985. 

William CA. Goldstone F. Greenham J. Flavonoids, cinnamic acids and coumarins from the different tissues and medicinal preparations of Taraxacum officinalis. Phytochemistry, 42(1): 121-127, 1996.

 

Hook I. McGee A. Henman M. Evaluation of Dandelion for diuretic activity and variation in potassium content. Int. J. Pharmacog.  31:29-34, 1993.

 

 Wichtl M. Herbal Drugs and Phytopharmaceuticals. Boca Raton, FL: CRC Press, 1994, 486–9.

 

Bradley PR (ed). British Herbal Compendium, Vol 1. Bournemouth, Dorset, UK: British Herbal Medicine Association, 1992, 73–5.

 

Racz-Kitilla E, Racz G, Solomon A. The action of Taraxacum officinale extracts on body weight and diuresis of laboratory animals. Planta Med 1974:26:212–7.

 

 Kuusi T, Pyylaso H, Autio K. The bitterness properties of dandelion. II. Chemical investigations. Lebensm-Wiss Technol 1985;18:347–9.

 

 Böhm K. Choleretic action of some medicinal plants. Arzneimittelforschung 1959;9:376–8. 

 

Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative Medicine Communications, 1998, 119–20.

 

 Foster S. Herbs for Your Health. Loveland, CO: Interweave Press, 1996, 26–7.

 

Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative Medicine Communications, 1998, 118–9.


\

 

מחקרים קליניים הקשורים לרכיבי תה אסמאדן
BIBIKIOGRAPHY
 

Nicholas H.J. (1964). Isolation of Marrubiin, a sterol, and sesquiterpene from Marrubium vulgare. J Pharm. Sci. 53: 895-899.
 
Henderson, M.S. and McCrindle R.Premarrubin .(1969). A diterpene from Marrubium vulgare. J. Chem Soc. (c) 2014-2015.
 
Bradley; R.P. (Ed.) (1992). British Herbal Compendium. Great Britain Herbal Medicine Association. Vol 1 P.218.
 
פליישר, א. (1982) תבלין אורגנו אמיתי, כיצד? השדה ס"ג: 246-249
 
Wichtl, M.(1994), Herbal Drugs and Phytopharmaceuticals, Stuttgart: CRC Press Medpharm Scientific Publishers. 121-123.
 
Wagner, H. Seligmann, O. (1985). Liver Theraputic Drugs from Silybium marianum. In H.M. Chang, H.W. Yeung, W.W. Tso, and A. Koo (Eds.,) Advances in Chinese Materials Research, Singapore: World Scientific Publishing 247-256.

 

 כל האמור להלן הינו לידיעה כללית ואינו מהווה המלצה רפואית. 

לפני השימוש מומלץ לקרוא חומר נוסף ולהתייעץ עם אנשי מקצוע.

בכל מקרה של בעיה רפואית יש לפנות לרופא המטפל.

האתר נבנה במערכת 2all | בניית אתרים